To access this element change to forms mode OFF
Grant Award View - GA69438
Testosterone therapy for the treatment of non-alcoholic fatty liver...
GA ID:
GA69438
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
20-Jan-2020
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$132,741.92
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Testosterone therapy for the treatment of non-alcoholic fatty liver disease
Purpose:
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in Australia, damaging the liver from inflammation due to excessive fat. It can cause liver failure and liver cancer and currently has no treatment. Low testosterone (T) levels are common in men with NAFLD and may worsen the disease. It is plausible that T therapy could reduce liver fat in NAFLD patients. I plan to run a clinical trial investigating the effects of T therapy in men with NAFLD and low T levels.
GO ID:
GO Title:
NHMRC Postgraduate Scholarships for funding commencing in 2020
Internal Reference ID:
GNT1191028
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA